Tomás Pascual

Clinical, pathological, and PAM50 gene expression features of HER2-low breast cancer

Francesco Schettini, Núria Chic, Fara Brasó‐Maristany et al. · npj Breast Cancer · 2021 · 691 citations · Full text

Medicine, Cancer Biology, Oncology +10

Immune-Related Gene Expression Profiling After PD-1 Blockade in Non–Small Cell Lung Carcinoma, Head and Neck Squamous Cell Carcinoma, and Melanoma

Aleix Prat, Alejandro Navarro, Laia Paré et al. · Cancer Research · 2017 · 477 citations

Medicine, Immunology, Oncology +16

Frequency and spectrum of PIK3CA somatic mutations in breast cancer

Olga Martínez‐Sáez, Núria Chic, Tomás Pascual et al. · Breast Cancer Research · 2020 · 376 citations · Full text

Medicine, Molecular Medicine, Oncology +17

Ribociclib plus letrozole versus chemotherapy for postmenopausal women with hormone receptor-positive, HER2-negative, luminal B breast cancer (CORALLEEN): an open-label, multicentre, randomised, phase 2 trial

Aleix Prat, Cristina Saura, Tomás Pascual et al. · The Lancet Oncology · 2019 · 201 citations

Medicine, Oncology, Pharmacology +16

HER2-Enriched Subtype and ERBB2 Expression in HER2-Positive Breast Cancer Treated with Dual HER2 Blockade

Aleix Prat, Tomás Pascual, Carmine De Angelis et al. · JNCI Journal of the National Cancer Institute · 2019 · 169 citations · Full text

Medicine, Oncology, Pharmacology +17